Microfluidic biochips represent a transformative technology that miniaturises laboratory functions onto single chip platforms, revolutionising biochemical assays, point‐of‐care diagnostics, and ...

The microfluidics market offers opportunities in diagnostic healthcare, driven by the demand for precise, rapid PoCT solutions and reduced hospital visits. Adoption by key players like Abbott and ...

Novel techniques, automated machines, sophisticated synthetic and bioprospected polymerases, and developments in symbiotic sequencing technologies have transformed PCR into a multifaceted, adaptable ...